Farmonika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 12,664 | 17,447 | 25,811 | 15,438 | 4,865 | 43,641 | 55,782 | 75,011 |
| Profit before tax | 139 | 479 | 5,540 | -4,486 | -225 | 3,906 | 103 | 4,881 |
| Net profit | 132 | 455 | 5,263 | -4,486 | -225 | 3,711 | 97 | 4,588 |
| Equity | 1,093 | 1,548 | 6,811 | 2,325 | 2,100 | 5,811 | 1,408 | 5,996 |
| Liabilities | - | - | - | - | 0 | 195 | 2,979 | 495 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 1,100 | 1,572 | 7,088 | 2,325 | 2,100 | 6,006 | 4,387 | 6,491 |
| Total assets | 1,100 | 1,572 | 7,088 | 2,325 | 2,100 | 6,006 | 4,387 | 6,491 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 1,590 | 139 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +21.3% | +37.8% | +47.9% | -40.2% | -68.5% | +797.0% | +27.8% | +34.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.0% | 28.9% | 74.3% | -192.9% | -10.7% | 61.8% | 2.2% | 70.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 12.1% | 29.4% | 77.3% | -192.9% | -10.7% | 63.9% | 6.9% | 76.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | 2.6% | 20.4% | -29.1% | -4.6% | 8.5% | 0.2% | 6.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.1% | 2.7% | 21.5% | -29.1% | -4.6% | 9.0% | 0.2% | 6.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 0.0 | 2.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Farmonika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-01 | 2026-09-01 | 8.33 |
| 2026-08-01 | 2026-08-31 | 8.35 |
| 2026-06-02 | 2026-06-30 | 8.39 |
| 2025-07-01 | 2025-07-31 | 8.49 |
| 2023-07-19 | 2023-07-31 | 1556.24 |
Farmonika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-12-18 | 2024-12-28 | 0.59 |
| 2024-12-03 | 2024-12-17 | 0.43 |
| 2024-11-28 | 2024-12-02 | 310.11 |
| 2024-11-20 | 2024-11-23 | 9.03 |
| 2024-11-03 | 2024-11-19 | 8.7 |
| 2024-10-16 | 2024-10-16 | 760.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Farmonika, MB (company code 304426057) is a small partnership engaged in activities of advertising agencies. In 2025, it generated revenue of €75.0K, up from €55.8K in 2024 and €43.6K in 2023, confirming a steady upward sales trend over the latest three years. Net profit reached €4.6K in 2025 after only €97 in 2024, compared with €3.7K in 2023. The profit margin improved to 6.1% in 2025, recovering from 0.2% in 2024, although it remained below the 8.5% recorded in 2023. At the end of 2025, total assets stood at €6.5K, equity at €6.0K and liabilities at €495, indicating a very low debt burden and a strongly equity-funded balance sheet. Revenue growth was 34.5% year on year and 71.9% over two years. The business also produced high sales relative to its asset base, with asset turnover of 11.56x. Profitability ratios were strong in 2025, although they should be interpreted in light of the small equity base.